NTRK Fusion Positive
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities (NCT07394374) | Cullgen (Shanghai),Inc | 2023-06-20 |
Track NTRK Fusion Positive automatically
Every clearance here is in the API, with alerts when new ones post.